DK1028110T3 - Hidtil ukendte dihydronaphthalenforbindelser og fremgangsmåde til fremstilling deraf - Google Patents
Hidtil ukendte dihydronaphthalenforbindelser og fremgangsmåde til fremstilling derafInfo
- Publication number
- DK1028110T3 DK1028110T3 DK98945556T DK98945556T DK1028110T3 DK 1028110 T3 DK1028110 T3 DK 1028110T3 DK 98945556 T DK98945556 T DK 98945556T DK 98945556 T DK98945556 T DK 98945556T DK 1028110 T3 DK1028110 T3 DK 1028110T3
- Authority
- DK
- Denmark
- Prior art keywords
- inhibiting activity
- cancer
- preparation
- new
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/06—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom
- C07D213/16—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom containing only hydrogen and carbon atoms in addition to the ring nitrogen atom containing only one pyridine ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Diabetes (AREA)
- Endocrinology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Hydrogenated Pyridines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP28426397 | 1997-10-02 | ||
| PCT/JP1998/004426 WO1999018075A1 (en) | 1997-10-02 | 1998-10-01 | Novel dihydronaphthalene compounds and process for producing the same |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1028110T3 true DK1028110T3 (da) | 2004-07-19 |
Family
ID=17676271
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK98945556T DK1028110T3 (da) | 1997-10-02 | 1998-10-01 | Hidtil ukendte dihydronaphthalenforbindelser og fremgangsmåde til fremstilling deraf |
Country Status (17)
| Country | Link |
|---|---|
| EP (1) | EP1028110B1 (da) |
| KR (1) | KR20000069426A (da) |
| CN (1) | CN1117732C (da) |
| AT (1) | ATE264304T1 (da) |
| AU (1) | AU743405B2 (da) |
| CA (1) | CA2298527A1 (da) |
| DE (1) | DE69823222T2 (da) |
| DK (1) | DK1028110T3 (da) |
| ES (1) | ES2218853T3 (da) |
| FI (1) | FI20000207A7 (da) |
| HU (1) | HUP0004037A3 (da) |
| IL (1) | IL133483A0 (da) |
| NO (1) | NO315044B1 (da) |
| NZ (1) | NZ501822A (da) |
| RU (1) | RU2203890C2 (da) |
| WO (1) | WO1999018075A1 (da) |
| ZA (1) | ZA988954B (da) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR100287366B1 (ko) | 1997-11-24 | 2001-04-16 | 윤순조 | 엠피이지 방식을 이용한 휴대용 음향 재생장치 및 방법 |
| US7001926B2 (en) | 2000-03-10 | 2006-02-21 | Oxigene, Inc. | Tubulin binding agents and corresponding prodrug constructs |
| TWI283669B (en) * | 1999-06-10 | 2007-07-11 | Allergan Inc | Compounds and method of treatment having agonist-like activity selective at alpha 2B or 2B/2C adrenergic receptors |
| US6849656B1 (en) | 1999-09-17 | 2005-02-01 | Baylor University | Indole-containing and combretastatin-related anti-mitotic and anti-tubulin polymerization agents |
| WO2001030764A1 (en) | 1999-10-22 | 2001-05-03 | Takeda Chemical Industries, Ltd. | 1-substituted phenyl-1-(1h-imidazol-4-yl) alcohols, process for producing the same and use thereof |
| JP4520012B2 (ja) * | 1999-10-22 | 2010-08-04 | 武田薬品工業株式会社 | １−置換−１−（１ｈ−イミダゾール−４−イル）メタノール類 |
| JP4616454B2 (ja) * | 1999-10-22 | 2011-01-19 | 武田薬品工業株式会社 | １−置換フェニル−１−（１ｈ−イミダゾール−４−イル）アルコール類、その製造法および用途 |
| US7091240B2 (en) | 2000-03-10 | 2006-08-15 | Oxigene, Inc. | Tubulin binding ligands and corresponding prodrug constructs |
| WO2001068654A2 (en) | 2000-03-10 | 2001-09-20 | Baylor University | Tubulin binding ligands and corresponding prodrug constructs |
| ES2260303T3 (es) | 2000-11-17 | 2006-11-01 | Takeda Pharmaceutical Company Limited | Derivados de imidazol, metodo para su produccion, y su uso. |
| WO2002040470A1 (en) | 2000-11-20 | 2002-05-23 | Takeda Chemical Industries, Ltd. | Imidazole derivatives, process for their preparation and their use |
| WO2002046186A1 (en) | 2000-12-08 | 2002-06-13 | Takeda Chemical Industries, Ltd. | Substituted thiazole derivatives bearing 3-pyridyl groups, process for preparing the same and use thereof |
| BR0307413A (pt) * | 2002-01-25 | 2005-05-24 | Pharmacia Corp | Terapêutica com bloqueadores de aldosterona para prevenção ou tratamento de patologias relacionadas com inflamação |
| US7456214B2 (en) | 2004-05-03 | 2008-11-25 | Baylor University | Chromene-containing compounds with anti-tubulin and vascular targeting activity |
| UY32730A (es) | 2009-06-26 | 2011-01-31 | Novartis Ag | Inhibidores de cyp17 |
| KR101823275B1 (ko) | 2010-08-04 | 2018-03-08 | 펠피큐어 파마슈티걸즈 아이엔씨 | 전립선 암종의 치료를 위한 병용 요법 |
| US8946260B2 (en) | 2010-09-16 | 2015-02-03 | Novartis Ag | 17α-hydroxylase/C17,20-lyase inhibitors |
| AU2012249421B9 (en) | 2011-04-28 | 2015-10-22 | Novartis Ag | 17alpha-hydroxylase/C17,20-lyase inhibitors |
| EP2968219B1 (en) | 2013-03-14 | 2019-04-24 | Pellficure Pharmaceuticals, Inc. | Novel therapy for prostate carcinoma |
| EP3191087A1 (en) | 2014-09-12 | 2017-07-19 | Pellficure Pharmaceuticals, Inc. | Compositions and methods for treatment of prostate carcinoma |
| EP3528799A1 (en) | 2016-10-24 | 2019-08-28 | Pellficure Pharmaceuticals, Inc. | Pharmaceutical compositions of 5-hydroxy-2-methylnaphthalene-1, 4-dione |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5681566A (en) * | 1979-12-05 | 1981-07-03 | Yoshitomi Pharmaceut Ind Ltd | Imidazole derivative |
| ZA825413B (en) * | 1981-08-26 | 1983-06-29 | Pfizer | Thromboxane synthetase inhibitors, processes for their production, and pharmaceutical compositions comprising them |
| US4540705A (en) * | 1983-03-14 | 1985-09-10 | Sterling Drug Inc. | Antidepressant imidazolines and related compounds |
| PH22076A (en) * | 1983-08-25 | 1988-05-20 | Daiichi Seiyaku Co | Benzocycloalkane derivative |
| JPS61186348A (ja) * | 1985-02-14 | 1986-08-20 | Dai Ichi Seiyaku Co Ltd | ナフタレン誘導体 |
| US4661596A (en) * | 1985-02-21 | 1987-04-28 | American Home Products Corporation | Quinolinyl (or pyridinyl) methoxy substituted naphthalene compounds as antiallergic agents |
| DE3508905A1 (de) * | 1985-03-13 | 1986-09-18 | Hoechst Ag, 6230 Frankfurt | Neue imidazolylverbindungen und verfahren zu ihrer herstellung |
| WO1989003681A1 (en) * | 1987-10-19 | 1989-05-05 | Pfizer Inc. | Substituted tetralins, chromans and related compounds in the treatment of asthma |
| JPH06166674A (ja) * | 1992-12-01 | 1994-06-14 | Tokyo Tanabe Co Ltd | テトラリン化合物 |
| JP3338905B2 (ja) * | 1993-05-13 | 2002-10-28 | 帝国臓器製薬株式会社 | ６位置換ステロイド誘導体 |
| PL313769A1 (en) * | 1993-09-30 | 1996-07-22 | Yamanouchi Pharma Co Ltd | Azole derivative and pharmaceutical composition thereof |
| FR2787451B1 (fr) * | 1998-12-18 | 2001-01-26 | Adir | Nouveaux composes imidazoliniques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent |
-
1998
- 1998-10-01 IL IL13348398A patent/IL133483A0/xx unknown
- 1998-10-01 AT AT98945556T patent/ATE264304T1/de not_active IP Right Cessation
- 1998-10-01 NZ NZ501822A patent/NZ501822A/en unknown
- 1998-10-01 DE DE69823222T patent/DE69823222T2/de not_active Expired - Fee Related
- 1998-10-01 AU AU92810/98A patent/AU743405B2/en not_active Ceased
- 1998-10-01 RU RU99127323/04A patent/RU2203890C2/ru not_active IP Right Cessation
- 1998-10-01 CA CA002298527A patent/CA2298527A1/en not_active Abandoned
- 1998-10-01 DK DK98945556T patent/DK1028110T3/da active
- 1998-10-01 KR KR1019997005209A patent/KR20000069426A/ko not_active Ceased
- 1998-10-01 EP EP98945556A patent/EP1028110B1/en not_active Expired - Lifetime
- 1998-10-01 HU HU0004037A patent/HUP0004037A3/hu unknown
- 1998-10-01 ES ES98945556T patent/ES2218853T3/es not_active Expired - Lifetime
- 1998-10-01 CN CN98808436A patent/CN1117732C/zh not_active Expired - Fee Related
- 1998-10-01 WO PCT/JP1998/004426 patent/WO1999018075A1/ja not_active Ceased
- 1998-10-01 ZA ZA988954A patent/ZA988954B/xx unknown
-
2000
- 2000-02-01 FI FI20000207A patent/FI20000207A7/fi not_active Application Discontinuation
- 2000-03-10 NO NO20001289A patent/NO315044B1/no unknown
Also Published As
| Publication number | Publication date |
|---|---|
| EP1028110A1 (en) | 2000-08-16 |
| IL133483A0 (en) | 2001-04-30 |
| EP1028110B1 (en) | 2004-04-14 |
| AU9281098A (en) | 1999-04-27 |
| ZA988954B (en) | 1999-04-12 |
| NO315044B1 (no) | 2003-06-30 |
| EP1028110A4 (en) | 2001-05-23 |
| ATE264304T1 (de) | 2004-04-15 |
| NO20001289L (no) | 2000-03-10 |
| DE69823222T2 (de) | 2005-04-14 |
| HUP0004037A3 (en) | 2002-03-28 |
| FI20000207L (fi) | 2000-02-01 |
| HUP0004037A2 (hu) | 2001-10-28 |
| NZ501822A (en) | 2001-12-21 |
| NO20001289D0 (no) | 2000-03-10 |
| CA2298527A1 (en) | 1999-04-15 |
| WO1999018075A1 (en) | 1999-04-15 |
| DE69823222D1 (de) | 2004-05-19 |
| CN1268120A (zh) | 2000-09-27 |
| RU2203890C2 (ru) | 2003-05-10 |
| AU743405B2 (en) | 2002-01-24 |
| CN1117732C (zh) | 2003-08-13 |
| KR20000069426A (ko) | 2000-11-25 |
| FI20000207A7 (fi) | 2000-02-01 |
| ES2218853T3 (es) | 2004-11-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK1028110T3 (da) | Hidtil ukendte dihydronaphthalenforbindelser og fremgangsmåde til fremstilling deraf | |
| YU596A (sh) | Estrogen agonisti/antagonisti | |
| DE69838177D1 (de) | Androgensyntheseinhibitoren | |
| BR0006265A (pt) | Composto de tetrahidroisoquinolinas como agonistas/antagonistas de estrogênios | |
| CY1107721T1 (el) | Παραγωγα τυροζινης | |
| BR9710255A (pt) | Método para o tratamento de cáncer composto de retinóide de adamantila composição farmacéutica ou cosmética de matéria método de tratamento ou de prevenção e método para controlar | |
| DE69935335D1 (de) | Pyrazole als modulatoren des östrogenrezeptors | |
| PT971585E (pt) | Compostos tetraciclina no tratamento de certos tipos de cancros | |
| DK1079824T3 (da) | Triterpen-sammensætninger og fremgangsmåder til anvendelse deraf | |
| YU63703A (sh) | 6-supstituisani pirido-pirimidini | |
| BR0112857A (pt) | Compostos 2-(4-piridil)amino-6-dialcoxifenil-pirido-[2,3-d]pirimidin- 7-onas | |
| TR199900239T2 (da) | ||
| ATE272066T1 (de) | Metallkomplexe als hyrdosilylierungskatalysatoren | |
| MY120090A (en) | Chemical compounds. | |
| ATE423557T1 (de) | Carbocyclische kaliumkanalhemmer | |
| ATE290382T1 (de) | Heterozyklische kalium-kanal inhibitoren | |
| DK1100789T3 (da) | Substituerede benzoylcyclohexandioner | |
| MXPA01008347A (es) | Compuestos quimicos. | |
| DE60217854D1 (de) | Herstellung von agonisten und antagonisten von cholecystokinin und ihre therapeutische und diagnostische verwendung | |
| EP0640595A4 (en) | NEW, SUBSTITUTED TERTIARY AMINES AND THEIR SALTS. | |
| AU3029297A (en) | 7alpha-(5-methylaminopentyl)-estratrienes, process for their production, pharmaceutical preparations that contain these 7alpha-(5-methylaminopentyl)-estratrienes as well as their use for the production of pharmaceutical agents | |
| TR199902971T2 (xx) | Selim prostat hiperplazisinin tedavisinde yararl� aril ikameli piperazinler. | |
| SE9604582D0 (sv) | Novel compounds | |
| PT880540E (pt) | 17-beta-ciclopropil-(amino/oxi)-4-azaesteroides como inibidores activos de 5-alfa-redutase e c17-c20-liase de testosterona | |
| NO20014937D0 (no) | Naturlige pseudomycinprodukter |